Merit Medical Systems Inc
MMSI
ISIN US5898891040 / Valor 951136
Merit Medical Systems Inc
UMushroom community rating:
About company
Merit Medical Systems Inc, established in 1987, is a prominent manufacturer and distributor of disposable medical devices utilized in various interventional, diagnostic, and therapeutic procedures, with a focus on cardiology, radiology, oncology, critical care, and endoscopy. The company caters to hospitals and physicians globally, boasting a workforce of around 7,000 employees.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.08.2024):
Revenue Growth
Merit Medical Systems Inc. reported revenue of $338.0 million for the second quarter of 2024, marking an increase of 5.6% compared to the same period in 2023. On a constant currency basis, revenue grew by 6.6%, and organic constant currency revenue increased by 5.0% year-over-year.
Operating Margins
For the second quarter of 2024, Merit Medical Systems Inc. achieved a GAAP operating margin of 13.6%, up from 9.0% in the prior year period. The non-GAAP operating margin also improved, reaching 20.1% compared to 19.1% in the second quarter of 2023.
Earnings Per Share
Merit Medical Systems Inc. reported GAAP earnings per share (EPS) of $0.61 for the second quarter of 2024, a significant increase of 75.7% from the same quarter in 2023. Non-GAAP EPS was $0.92, up 16.8% year-over-year.
Segment Performance
In the second quarter of 2024, Merit Medical Systems Inc.'s Cardiovascular segment saw notable growth. Peripheral Intervention revenue increased by 10.6% to $139.2 million, while Cardiac Intervention revenue remained relatively flat at $93.9 million. The Endoscopy segment also performed well, with Endoscopy Devices revenue growing by 16.0% to $10.2 million.
Updated Financial Guidance
Merit Medical Systems Inc. has updated its financial guidance for the fiscal year ending December 31, 2024. The company now expects net sales to be between $1.335 billion and $1.345 billion, representing a 6% to 7% year-over-year increase. Non-GAAP earnings per share are projected to be in the range of $3.27 to $3.35, reflecting a 15% to 17% increase from the prior year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
5746 M
Market cap (USD)
144,146
Daily traded volume (Shares)
100.18 / 97.63
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
